201 related articles for article (PubMed ID: 22948159)
1. Constant domain-regulated antibody catalysis.
Sapparapu G; Planque S; Mitsuda Y; McLean G; Nishiyama Y; Paul S
J Biol Chem; 2012 Oct; 287(43):36096-104. PubMed ID: 22948159
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring proteolytic antibodies: selective immunoglobulin M-catalyzed hydrolysis of HIV gp120.
Paul S; Karle S; Planque S; Taguchi H; Salas M; Nishiyama Y; Handy B; Hunter R; Edmundson A; Hanson C
J Biol Chem; 2004 Sep; 279(38):39611-9. PubMed ID: 15269209
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.
Sapparapu G; Planque SA; Nishiyama Y; Foung SK; Paul S
J Biol Chem; 2009 Sep; 284(36):24622-33. PubMed ID: 19542217
[TBL] [Abstract][Full Text] [Related]
4. Physiological IgM class catalytic antibodies selective for transthyretin amyloid.
Planque SA; Nishiyama Y; Hara M; Sonoda S; Murphy SK; Watanabe K; Mitsuda Y; Brown EL; Massey RJ; Primmer SR; O'Nuallain B; Paul S
J Biol Chem; 2014 May; 289(19):13243-58. PubMed ID: 24648510
[TBL] [Abstract][Full Text] [Related]
5. Human IgG1 Cgamma1 domain is crucial for the bioactivity of the engineered anti-CD20 antibodies.
Geng S; Feng J; Li Y; Kang X; Sun Y; Gu X; Huang Y; Chang H; Shen BF
Cell Mol Immunol; 2007 Apr; 4(2):121-5. PubMed ID: 17484806
[TBL] [Abstract][Full Text] [Related]
6. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells.
Shlomchik MJ; Nemazee DA; Sato VL; Van Snick J; Carson DA; Weigert MG
J Exp Med; 1986 Aug; 164(2):407-27. PubMed ID: 3088205
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of multicatalytic monoclonal antibodies.
Zein HS; da Silva JA; Miyatake K
Mol Immunol; 2010 May; 47(9):1747-56. PubMed ID: 20356628
[TBL] [Abstract][Full Text] [Related]
8. Nature and nurture of catalytic antibodies.
Paul S; Planque SA; Nishiyama Y; Hanson CV; Massey RJ
Adv Exp Med Biol; 2012; 750():56-75. PubMed ID: 22903666
[TBL] [Abstract][Full Text] [Related]
9. Ontogeny of proteolytic immunity: IgM serine proteases.
Planque S; Bangale Y; Song XT; Karle S; Taguchi H; Poindexter B; Bick R; Edmundson A; Nishiyama Y; Paul S
J Biol Chem; 2004 Apr; 279(14):14024-32. PubMed ID: 14726510
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide.
Preston MJ; Gerçeker AA; Reff ME; Pier GB
Infect Immun; 1998 Sep; 66(9):4137-42. PubMed ID: 9712759
[TBL] [Abstract][Full Text] [Related]
11. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
[TBL] [Abstract][Full Text] [Related]
12. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
[TBL] [Abstract][Full Text] [Related]
13. Preparation of human IgG and IgM monoclonal antibodies for MK-1/Ep-CAM by using human immunoglobulin gene-transferred mouse and gene cloning of their variable regions.
Kuroki M; Yamada H; Shibaguchi H; Hachimine K; Hirose Y; Kinugasa T; Ishida I; Kuroki M
Anticancer Res; 2005; 25(6A):3733-9. PubMed ID: 16302733
[TBL] [Abstract][Full Text] [Related]
14. Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection.
Planque S; Mitsuda Y; Taguchi H; Salas M; Morris MK; Nishiyama Y; Kyle R; Okhuysen P; Escobar M; Hunter R; Sheppard HW; Hanson C; Paul S
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1541-54. PubMed ID: 18160012
[TBL] [Abstract][Full Text] [Related]
15. Structure of the VH-D-JH segments of human natural polyreactive IgM and IgG antibodies. Use of germline or somatically mutated forms of commonly expressed VH genes.
Ikematsu H; Schettino EW; Casali P
Ann N Y Acad Sci; 1995 Sep; 764():362-9. PubMed ID: 7486547
[No Abstract] [Full Text] [Related]
16. Repertoire diversification in mice with an IgH-locus-targeted transgene for the rearranged VH domain of a physiologically selected anti-ssDNA antibody.
Li J; Geissal ED; Li W; Stollar BD
Mol Immunol; 2005 Aug; 42(12):1475-84. PubMed ID: 15950740
[TBL] [Abstract][Full Text] [Related]
17. Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis.
Saveliev AN; Ivanen DR; Kulminskaya AA; Ershova NA; Kanyshkova TG; Buneva VN; Mogelnitskii AS; Doronin BM; Favorova OO; Nevinsky GA; Neustroev KN
Immunol Lett; 2003 May; 86(3):291-7. PubMed ID: 12706534
[TBL] [Abstract][Full Text] [Related]
18. The integrity of the ball-and-socket joint between V and C domains is essential for complete activity of a humanized antibody.
Landolfi NF; Thakur AB; Fu H; Vásquez M; Queen C; Tsurushita N
J Immunol; 2001 Feb; 166(3):1748-54. PubMed ID: 11160220
[TBL] [Abstract][Full Text] [Related]
19. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.
Nishiyama Y; Bhatia G; Bangale Y; Planque S; Mitsuda Y; Taguchi H; Karle S; Paul S
J Biol Chem; 2004 Feb; 279(9):7877-83. PubMed ID: 14676184
[TBL] [Abstract][Full Text] [Related]
20. Recognition of IgG-derived peptides by a human IgM with an unusual combining site.
Yuriev E; Ramsland PA; Edmundson AB
Scand J Immunol; 2002 Mar; 55(3):242-55. PubMed ID: 11940231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
